These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Synthesis, DNA binding and cytotoxicity of 1-[[omega-(9-acridinyl)amino]alkyl]carbonyl -3-(chloromethyl)-6-hydroxyindolines, a new class of DNA-targeted alkylating agents.
    Author: Fan JY, Tercel M, Denny WA.
    Journal: Anticancer Drug Des; 1997 Jun; 12(4):277-93. PubMed ID: 9199660.
    Abstract:
    We report the first synthesis of examples of the seco-CI DNA alkylating moiety 3-(chloromethyl)-6-hydroxyindoline linked to a 9-aminoacridine DNA-intercalating unit (compounds 1a-1c). The sequence-specificity of DNA alkylation by these compounds was studied by the gel electrophoresis cleavage assay. In contrast to the known trimethoxyindole-linked compound (1d), which alkylates exclusively at N3 of adenines in the minor groove, the acridine-linked analogues (1a-1c) alkylate predominantly at the N7 of guanines in the major groove (the first CI analogues reported to do so), although DNase I footprinting experiments show that the initial non-covalent binding of 1a-1c is not base sequence selective. DNA unwinding experiments show that the acridine moiety of 1a-1c remains intercalated after alkylation.
    [Abstract] [Full Text] [Related] [New Search]